HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 6-23-2023 Insider Buy |
Thomas Von Koch >10% Owner |
$3.40 CAGR » |
$4,999,999.20 1,470,588 shares |
| 6-23-2023 Insider Buy |
Randall Michael Giuffre Director |
$3.91 CAGR » |
$254,150.00 65,000 shares |
| 6-23-2023 Insider Buy |
Charles Pauling Semba Director |
$3.91 CAGR » |
$49,997.17 12,787 shares |
| 6-23-2023 Insider Buy |
Dietrich John Pauls President and CEO |
$3.91 CAGR » |
$49,997.17 12,787 shares |
| 6-23-2023 Insider Buy |
David J. Wambeke Chief Business Officer |
$3.91 CAGR » |
$150,003.24 38,364 shares |
| 4-10-2023 Insider Buy |
David J. Wambeke Chief Business Officer |
$1.60 CAGR » |
$750,000.00 468,750 shares |
| 12-2-2022 Insider Buy |
Thomas Von Koch >10% Owner |
$1.23 CAGR » |
$3,526,971.04 2,855,847 shares |
| 12-1-2022 Insider Buy |
Randall Michael Giuffre Director |
$1.20 CAGR » |
$80,462.65 67,228 shares |
| 7-8-2022 Insider Buy |
Thomas Von Koch >10% Owner |
$1.33 CAGR » |
$275,898.31 207,974 shares |
| 9-15-2021 Insider Buy |
Harry W. Alcorn Jr. SVP, Clinical Operations |
$3.80 CAGR » |
$56,959.50 15,000 shares |
| 8-16-2021 Insider Buy |
Amy L. Burroughs Director |
$3.15 CAGR » |
$141,592.50 44,950 shares |
| 8-16-2021 Insider Buy |
Harry W. Alcorn Jr. Senior VP, Clinical Operations |
$3.09 CAGR » |
$64,053.86 20,721 shares |
| 8-16-2021 Insider Buy |
Scott Kellen CFO and Secretary |
$3.15 CAGR » |
$31,463.00 10,000 shares |
| 12-4-2020 Insider Buy |
Richard D. Pilnik Director |
$5.37 CAGR » |
$53,697.00 10,000 shares |
| 11-9-2020 Insider Buy |
Scott Kellen CFO and Secretary |
$4.19 CAGR » |
$8,386.60 2,000 shares |
| 8-16-2019 Insider Buy |
Richard D. Pilnik Director |
$2.56 CAGR » |
$20,039.04 7,840 shares |
| 5-31-2019 Insider Buy |
Richard D. Pilnik Director |
$2.80 CAGR » |
$53,200.00 19,000 shares |
| 5-24-2019 Insider Buy |
Scott Kellen CFO and Secretary |
$2.94 CAGR » |
$11,770.00 4,000 shares |
| 12-11-2018 Insider Buy |
Richard D. Pilnik Director |
$4.00 CAGR » |
$25,000.00 6,250 shares |
| 12-11-2018 Insider Buy |
Todd A. Verdoorn Chief Scientific Officer |
$4.00 CAGR » |
$4,000.00 1,000 shares |
| 12-11-2018 Insider Buy |
Harry W. Alcorn Jr. Chief Medical Officer |
$4.00 CAGR » |
$4,000.00 1,000 shares |
Also See: Institutional Holders of DMAC
Also See: SEC filings
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 06/26/2023 | |
| End date: | 04/17/2024 | |
| Start price/share: | $4.40 | |
| End price/share: | $2.60 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -40.91% | |
| Annualized Gain: | -50.45% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $5,909.00 | |
| Years: | 0.81 | |
DMAC Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent DMAC insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding DMAC
 Free DMAC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the DMAC Insider Buying occurred are:
CWAN Insider Buying
|
